LONDON--(BUSINESS WIRE)--The inclination of patients and surgeons toward MI procedures using thoracic catheters is increasing significantly owing to the severe complications associated with ...
Company’s proprietary system used to treat initial five patients in first-in-human feasibility study for patients with atrial fibrillation HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback